P Neuhaus
Overview
Explore the profile of P Neuhaus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
797
Citations
5094
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adam R, Karam V, Delvart V, Trunecka P, Samuel D, Bechstein W, et al.
Am J Transplant
. 2015 Feb;
15(5):1267-82.
PMID: 25703527
This study was a retrospective analysis of the European Liver Transplant Registry (ELTR) performed to compare long-term outcomes with prolonged-release tacrolimus versus tacrolimus BD in liver transplantation (January 2008-December 2012)....
2.
Seehofer D, Neuhaus P
Zentralbl Chir
. 2014 Dec;
141(4):397-404.
PMID: 25525948
Background: Retrospective analyses have shown a 20-40 % incidence of R1 resection in hilar cholangiocarcinoma, which therefore represents a significant issue to be addressed. Methods: We have reviewed the literature...
3.
Faber W, Schoning W, Denecke T, Veltzke-Schlieker W, Neuhaus P, Pratschke J, et al.
Chirurg
. 2014 Aug;
86(7):682-6.
PMID: 25103618
Postoperative bile leaks represent a typical complication in liver surgery with a frequency ranging from 5 % to 12 % in large series. The treatment of choice is usually conservative....
4.
Sterneck M, Kaiser G, Heyne N, Richter N, Rauchfuss F, Pascher A, et al.
Am J Transplant
. 2014 Feb;
14(3):701-10.
PMID: 24502384
The feasibility of de novo everolimus without calcineurin inhibitor (CNI) therapy following liver transplantation was assessed in a multicenter, prospective, open-label trial. Liver transplant patients were randomized at 4 weeks...
5.
Gul S, Klein F, Puhl G, Neuhaus P
Langenbecks Arch Surg
. 2013 Dec;
399(1):127-33.
PMID: 24317465
Purpose: The success of liver transplantation (LT) is accompanied by an increased need for organs. The wider use of older donors and marginal organs with risk factors such as steatosis...
6.
Faber W, Stockmann M, Schirmer C, Mollerarnd A, Denecke T, Bahra M, et al.
Eur J Surg Oncol
. 2013 Nov;
40(2):208-13.
PMID: 24275202
Objective: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. The majority of patients with HCC have cirrhosis. Beside liver transplantation the resection is an established curative...
7.
Greten T, Malek N, Schmidt S, Arends J, Bartenstein P, Bechstein W, et al.
Z Gastroenterol
. 2013 Nov;
51(11):1269-326.
PMID: 24243572
The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for hepatocellular carcinoma (HCC) constitute an evidence- and consensus-based instrument that is aimed at improving the diagnosis...
8.
Denecke T, Grieser C, Neuhaus P, Bahra M
Rofo
. 2013 Oct;
186(1):23-9.
PMID: 24081785
Complete tumor resection is still the only potentially curative therapy option for patients with ductal adenocarcinoma of the pancreas. Surgical exploration is the gold standard for the determination of tumor...
9.
Kalmuk S, Neuhaus P, Pascher A
Chirurg
. 2013 Sep;
84(11):937-44.
PMID: 24071973
Liver and kidney transplantations have been performed for almost 50 years and is nowadays a routine procedure for the treatment of terminal liver failure and terminal-stage renal failure. Under given...
10.
Docke S, Lock J, Birkenfeld A, Hoppe S, Lieske S, Rieger A, et al.
Eur J Endocrinol
. 2013 Aug;
169(5):547-57.
PMID: 23935128
Objective: Adipose tissue-derived factors link non-alcoholic fatty liver disease (NAFLD) with obesity, which has also been reported for circulating chemerin. On the other hand, hepatic chemerin and chemokine-like receptor 1...